HEADER MEMBRANE PROTEIN 23-JUN-21 7F61 TITLE CRYSTAL STRUCTURE OF HUMAN HISTAMINE RECEPTOR H3R IN COMPLEX WITH TITLE 2 ANTAGONIST PF03654746 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTAMINE H3 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: H3R,HH3R,G-PROTEIN COUPLED RECEPTOR 97; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SOLUBLE CYTOCHROME B562; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: CYTOCHROME B-562; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HRH3, GPCR97; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 10 ORGANISM_TAXID: 562; SOURCE 11 GENE: CYBC; SOURCE 12 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, HISTAMINE RECEPTOR, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.PENG,H.ZHANG REVDAT 2 29-NOV-23 7F61 1 REMARK REVDAT 1 26-OCT-22 7F61 0 JRNL AUTH X.PENG,L.YANG,Z.LIU,S.LOU,S.MEI,M.LI,Z.CHEN,H.ZHANG JRNL TITL STRUCTURAL BASIS FOR RECOGNITION OF ANTIHISTAMINE DRUG BY JRNL TITL 2 HUMAN HISTAMINE RECEPTOR. JRNL REF NAT COMMUN V. 13 6105 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36243875 JRNL DOI 10.1038/S41467-022-33880-Y REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 15194 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.931 REMARK 3 FREE R VALUE TEST SET COUNT : 788 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1121 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.42 REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 49 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3255 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.02000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.284 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.353 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.000 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.600 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.864 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7F61 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1300022947. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0330 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16071 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.14600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.61000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: 4U15 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM CACODYLATE TRIHYDRATE, REMARK 280 PH6.4, 90MM SODIUM CITRATE, 34% PEG400, 2% DICHLOROMETHANE, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.56200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 82.81200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.56200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 82.81200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 242 REMARK 465 GLU A 243 REMARK 465 PRO A 244 REMARK 465 PRO A 245 REMARK 465 PRO A 246 REMARK 465 GLU A 247 REMARK 465 ALA A 248 REMARK 465 GLN A 249 REMARK 465 PRO A 250 REMARK 465 SER A 251 REMARK 465 PRO A 252 REMARK 465 PRO A 253 REMARK 465 PRO A 254 REMARK 465 PRO A 255 REMARK 465 PRO A 256 REMARK 465 GLY A 257 REMARK 465 CYS A 258 REMARK 465 TRP A 259 REMARK 465 GLY A 260 REMARK 465 CYS A 261 REMARK 465 TRP A 262 REMARK 465 GLN A 263 REMARK 465 LYS A 264 REMARK 465 GLY A 265 REMARK 465 HIS A 266 REMARK 465 GLY A 267 REMARK 465 GLU A 268 REMARK 465 ALA A 269 REMARK 465 MET A 270 REMARK 465 PRO A 271 REMARK 465 LEU A 272 REMARK 465 HIS A 273 REMARK 465 ARG A 274 REMARK 465 TYR A 275 REMARK 465 GLY A 276 REMARK 465 VAL A 277 REMARK 465 GLY A 278 REMARK 465 GLU A 279 REMARK 465 ALA A 280 REMARK 465 ALA A 281 REMARK 465 VAL A 282 REMARK 465 GLY A 283 REMARK 465 ALA A 284 REMARK 465 GLU A 285 REMARK 465 ALA A 286 REMARK 465 GLY A 287 REMARK 465 GLU A 288 REMARK 465 ALA A 289 REMARK 465 THR A 290 REMARK 465 LEU A 291 REMARK 465 GLY A 292 REMARK 465 GLY A 293 REMARK 465 GLY A 294 REMARK 465 GLY A 295 REMARK 465 GLY A 296 REMARK 465 GLY A 297 REMARK 465 GLY A 298 REMARK 465 SER A 299 REMARK 465 VAL A 300 REMARK 465 ALA A 301 REMARK 465 SER A 302 REMARK 465 PRO A 303 REMARK 465 THR A 304 REMARK 465 SER A 305 REMARK 465 SER A 306 REMARK 465 SER A 307 REMARK 465 GLY A 308 REMARK 465 SER A 309 REMARK 465 SER A 310 REMARK 465 SER A 311 REMARK 465 ARG A 312 REMARK 465 GLY A 313 REMARK 465 THR A 314 REMARK 465 GLU A 315 REMARK 465 ARG A 316 REMARK 465 PRO A 317 REMARK 465 ARG A 318 REMARK 465 SER A 319 REMARK 465 LEU A 320 REMARK 465 LYS A 321 REMARK 465 ARG A 322 REMARK 465 GLY A 323 REMARK 465 SER A 324 REMARK 465 LYS A 325 REMARK 465 PRO A 326 REMARK 465 SER A 327 REMARK 465 ALA A 328 REMARK 465 SER A 329 REMARK 465 SER A 330 REMARK 465 ALA A 331 REMARK 465 SER A 332 REMARK 465 LEU A 333 REMARK 465 GLU A 334 REMARK 465 LYS A 335 REMARK 465 ARG A 336 REMARK 465 MET A 337 REMARK 465 LYS A 338 REMARK 465 MET A 339 REMARK 465 VAL A 340 REMARK 465 SER A 341 REMARK 465 GLN A 342 REMARK 465 SER A 343 REMARK 465 PHE A 344 REMARK 465 THR A 345 REMARK 465 GLN A 346 REMARK 465 LYS A 433 REMARK 465 MET B -40 REMARK 465 LYS B -39 REMARK 465 THR B -38 REMARK 465 ILE B -37 REMARK 465 ILE B -36 REMARK 465 ALA B -35 REMARK 465 LEU B -34 REMARK 465 SER B -33 REMARK 465 TYR B -32 REMARK 465 ILE B -31 REMARK 465 PHE B -30 REMARK 465 CYS B -29 REMARK 465 LEU B -28 REMARK 465 VAL B -27 REMARK 465 PHE B -26 REMARK 465 ALA B -25 REMARK 465 ASP B -24 REMARK 465 TYR B -23 REMARK 465 LYS B -22 REMARK 465 ASP B -21 REMARK 465 ASP B -20 REMARK 465 ASP B -19 REMARK 465 ASP B -18 REMARK 465 LYS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 GLY B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 199 OG SER A 203 1.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 86 -62.13 -124.31 REMARK 500 PRO A 184 154.04 -49.16 REMARK 500 CYS A 428 47.56 -140.09 REMARK 500 PRO A 429 -4.43 -59.54 REMARK 500 ASP B 21 -22.52 -142.57 REMARK 500 REMARK 500 REMARK: NULL DBREF 7F61 A 27 433 UNP Q9Y5N1 HRH3_HUMAN 27 433 DBREF 7F61 B 1 106 UNP P0ABE7 C562_ECOLX 23 128 SEQADV 7F61 LYS A 121 UNP Q9Y5N1 SER 121 ENGINEERED MUTATION SEQADV 7F61 MET B -40 UNP P0ABE7 INITIATING METHIONINE SEQADV 7F61 LYS B -39 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 THR B -38 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ILE B -37 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ILE B -36 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ALA B -35 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 LEU B -34 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 SER B -33 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 TYR B -32 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ILE B -31 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 PHE B -30 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 CYS B -29 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 LEU B -28 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 VAL B -27 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 PHE B -26 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ALA B -25 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ASP B -24 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 TYR B -23 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 LYS B -22 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ASP B -21 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ASP B -20 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ASP B -19 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ASP B -18 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 LYS B -17 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -16 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -15 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -14 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -13 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -12 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -11 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -10 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -9 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -8 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 HIS B -7 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 GLU B -6 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 ASN B -5 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 LEU B -4 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 TYR B -3 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 PHE B -2 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 GLN B -1 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 GLY B 0 UNP P0ABE7 EXPRESSION TAG SEQADV 7F61 TRP B 7 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 7F61 ILE B 102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 7F61 LEU B 106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQRES 1 A 407 ARG GLY PHE SER ALA ALA TRP THR ALA VAL LEU ALA ALA SEQRES 2 A 407 LEU MET ALA LEU LEU ILE VAL ALA THR VAL LEU GLY ASN SEQRES 3 A 407 ALA LEU VAL MET LEU ALA PHE VAL ALA ASP SER SER LEU SEQRES 4 A 407 ARG THR GLN ASN ASN PHE PHE LEU LEU ASN LEU ALA ILE SEQRES 5 A 407 SER ASP PHE LEU VAL GLY ALA PHE CYS ILE PRO LEU TYR SEQRES 6 A 407 VAL PRO TYR VAL LEU THR GLY ARG TRP THR PHE GLY ARG SEQRES 7 A 407 GLY LEU CYS LYS LEU TRP LEU VAL VAL ASP TYR LEU LEU SEQRES 8 A 407 CYS THR SER LYS ALA PHE ASN ILE VAL LEU ILE SER TYR SEQRES 9 A 407 ASP ARG PHE LEU SER VAL THR ARG ALA VAL SER TYR ARG SEQRES 10 A 407 ALA GLN GLN GLY ASP THR ARG ARG ALA VAL ARG LYS MET SEQRES 11 A 407 LEU LEU VAL TRP VAL LEU ALA PHE LEU LEU TYR GLY PRO SEQRES 12 A 407 ALA ILE LEU SER TRP GLU TYR LEU SER GLY GLY SER SER SEQRES 13 A 407 ILE PRO GLU GLY HIS CYS TYR ALA GLU PHE PHE TYR ASN SEQRES 14 A 407 TRP TYR PHE LEU ILE THR ALA SER THR LEU GLU PHE PHE SEQRES 15 A 407 THR PRO PHE LEU SER VAL THR PHE PHE ASN LEU SER ILE SEQRES 16 A 407 TYR LEU ASN ILE GLN ARG ARG THR ARG LEU ARG LEU ASP SEQRES 17 A 407 GLY ALA ARG GLU ALA ALA GLY PRO GLU PRO PRO PRO GLU SEQRES 18 A 407 ALA GLN PRO SER PRO PRO PRO PRO PRO GLY CYS TRP GLY SEQRES 19 A 407 CYS TRP GLN LYS GLY HIS GLY GLU ALA MET PRO LEU HIS SEQRES 20 A 407 ARG TYR GLY VAL GLY GLU ALA ALA VAL GLY ALA GLU ALA SEQRES 21 A 407 GLY GLU ALA THR LEU GLY GLY GLY GLY GLY GLY GLY SER SEQRES 22 A 407 VAL ALA SER PRO THR SER SER SER GLY SER SER SER ARG SEQRES 23 A 407 GLY THR GLU ARG PRO ARG SER LEU LYS ARG GLY SER LYS SEQRES 24 A 407 PRO SER ALA SER SER ALA SER LEU GLU LYS ARG MET LYS SEQRES 25 A 407 MET VAL SER GLN SER PHE THR GLN ARG PHE ARG LEU SER SEQRES 26 A 407 ARG ASP ARG LYS VAL ALA LYS SER LEU ALA VAL ILE VAL SEQRES 27 A 407 SER ILE PHE GLY LEU CYS TRP ALA PRO TYR THR LEU LEU SEQRES 28 A 407 MET ILE ILE ARG ALA ALA CYS HIS GLY HIS CYS VAL PRO SEQRES 29 A 407 ASP TYR TRP TYR GLU THR SER PHE TRP LEU LEU TRP ALA SEQRES 30 A 407 ASN SER ALA VAL ASN PRO VAL LEU TYR PRO LEU CYS HIS SEQRES 31 A 407 HIS SER PHE ARG ARG ALA PHE THR LYS LEU LEU CYS PRO SEQRES 32 A 407 GLN LYS LEU LYS SEQRES 1 B 147 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 B 147 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP LYS HIS HIS SEQRES 3 B 147 HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 4 B 147 GLN GLY ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN SEQRES 5 B 147 ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA SEQRES 6 B 147 GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA SEQRES 7 B 147 LEU ASP ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP SEQRES 8 B 147 LYS SER PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS SEQRES 9 B 147 GLY PHE ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU SEQRES 10 B 147 LYS LEU ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA SEQRES 11 B 147 ALA ALA GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE SEQRES 12 B 147 GLN LYS TYR LEU HET 1IB A 501 23 HET CLR A 502 28 HETNAM 1IB N-ETHYL-3-FLUORANYL-3-[3-FLUORANYL-4-(PYRROLIDIN-1- HETNAM 2 1IB YLMETHYL)PHENYL]CYCLOBUTANE-1-CARBOXAMIDE HETNAM CLR CHOLESTEROL FORMUL 3 1IB C18 H24 F2 N2 O FORMUL 4 CLR C27 H46 O FORMUL 5 HOH *8(H2 O) HELIX 1 AA1 SER A 30 ASP A 62 1 33 HELIX 2 AA2 SER A 63 ARG A 66 5 4 HELIX 3 AA3 THR A 67 PHE A 86 1 20 HELIX 4 AA4 PHE A 86 GLY A 98 1 13 HELIX 5 AA5 PHE A 102 ARG A 138 1 37 HELIX 6 AA6 ARG A 138 GLN A 146 1 9 HELIX 7 AA7 ASP A 148 SER A 178 1 31 HELIX 8 AA8 ASN A 195 ARG A 230 1 36 HELIX 9 AA9 ASP A 234 GLY A 241 1 8 HELIX 10 AB1 PHE A 348 CYS A 384 1 37 HELIX 11 AB2 PRO A 390 HIS A 416 1 27 HELIX 12 AB3 HIS A 416 CYS A 428 1 13 HELIX 13 AB4 PRO A 429 LEU A 432 5 4 HELIX 14 AB5 ASP B 2 ALA B 20 1 19 HELIX 15 AB6 ASN B 22 LYS B 42 1 21 HELIX 16 AB7 PRO B 45 GLU B 49 5 5 HELIX 17 AB8 SER B 55 ASN B 80 1 26 HELIX 18 AB9 LYS B 83 ILE B 102 1 20 HELIX 19 AC1 GLN B 103 LEU B 106 5 4 SSBOND 1 CYS A 107 CYS A 188 1555 1555 2.10 SSBOND 2 CYS A 384 CYS A 388 1555 1555 2.03 CRYST1 71.124 165.624 42.651 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014060 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006038 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023446 0.00000